101 related articles for article (PubMed ID: 20624438)
21. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
[TBL] [Abstract][Full Text] [Related]
22. [Advances in the development of neutralizing therapies for sepsis].
Florencia Henning M; Garda H; Bakás L
Medicina (B Aires); 2006; 66(3):263-73. PubMed ID: 16871917
[TBL] [Abstract][Full Text] [Related]
23. A novel TLR4-binding peptide that inhibits LPS-induced activation of NF-kappaB and in vivo toxicity.
Sugiyama K; Muroi M; Tanamoto K
Eur J Pharmacol; 2008 Oct; 594(1-3):152-6. PubMed ID: 18700140
[TBL] [Abstract][Full Text] [Related]
24. In vivo IL-18 supplementation ameliorates lethal acute lung injury in burn-primed endotoxemic mice: a novel anti-inflammatory role of IL-18.
Sekine K; Fujishima S; Sasaki J; Ishizaka A; Aiso S; Aikawa N
Shock; 2009 Nov; 32(5):554-62. PubMed ID: 19197224
[TBL] [Abstract][Full Text] [Related]
25. [Anti-endotoxin effect of lanthanum chloride in vivo: an experimental study of mice].
Wang Y; Hu F; Guo F; Yuan K; Hu YY
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):242-7. PubMed ID: 15059548
[TBL] [Abstract][Full Text] [Related]
26. Lipopolysaccharide neutralization by the antibacterial peptide CM4.
Lin QP; Zhou LF; Li NN; Chen YQ; Li BC; Cai YF; Zhang SQ
Eur J Pharmacol; 2008 Oct; 596(1-3):160-5. PubMed ID: 18789317
[TBL] [Abstract][Full Text] [Related]
27. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
[TBL] [Abstract][Full Text] [Related]
28. Endotoxin-neutralizing activity of hen egg phosvitin.
Ma J; Wang H; Wang Y; Zhang S
Mol Immunol; 2013 Apr; 53(4):355-62. PubMed ID: 23079731
[TBL] [Abstract][Full Text] [Related]
29. Bioactive peptides derived from the Limulus anti-lipopolysaccharide factor: structure-activity relationships and formation of mixed peptide/lipid complexes.
Mora P; López De La Paz M; Pérez-Payá E
J Pept Sci; 2008 Aug; 14(8):963-71. PubMed ID: 18383433
[TBL] [Abstract][Full Text] [Related]
30. Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages.
Chen RM; Chen TG; Chen TL; Lin LL; Chang CC; Chang HC; Wu CH
Ann N Y Acad Sci; 2005 May; 1042():262-71. PubMed ID: 15965071
[TBL] [Abstract][Full Text] [Related]
31. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL
Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
[TBL] [Abstract][Full Text] [Related]
32. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung.
Giebelen IA; van Westerloo DJ; LaRosa GJ; de Vos AF; van der Poll T
Shock; 2007 Dec; 28(6):700-3. PubMed ID: 17621262
[TBL] [Abstract][Full Text] [Related]
33. An anti-endotoxin peptide that generates from the amino-terminal domain of complement regulatory protein C1 inhibitor.
Zhang H; Li J; Barrington RA; Liang G; Qin G; Liu DX
Biochem Biophys Res Commun; 2007 Jul; 359(2):285-91. PubMed ID: 17543887
[TBL] [Abstract][Full Text] [Related]
34. The antimicrobial antiproteinase elafin binds to lipopolysaccharide and modulates macrophage responses.
McMichael JW; Roghanian A; Jiang L; Ramage R; Sallenave JM
Am J Respir Cell Mol Biol; 2005 May; 32(5):443-52. PubMed ID: 15668324
[TBL] [Abstract][Full Text] [Related]
35. Limulus antilipopolysaccharide factor prevents mortality late in the course of endotoxemia.
Roth RI; Su D; Child AH; Wainwright NR; Levin J
J Infect Dis; 1998 Feb; 177(2):388-94. PubMed ID: 9466526
[TBL] [Abstract][Full Text] [Related]
36. Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation.
Wu GJ; Chen TL; Ueng YF; Chen RM
Toxicol Appl Pharmacol; 2008 Apr; 228(1):105-13. PubMed ID: 18191973
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages.
Kanno S; Shouji A; Tomizawa A; Hiura T; Osanai Y; Ujibe M; Obara Y; Nakahata N; Ishikawa M
Life Sci; 2006 Jan; 78(7):673-81. PubMed ID: 16137700
[TBL] [Abstract][Full Text] [Related]
38. The novel beta-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo.
Motzkus D; Schulz-Maronde S; Heitland A; Schulz A; Forssmann WG; Jübner M; Maronde E
FASEB J; 2006 Aug; 20(10):1701-2. PubMed ID: 16790530
[TBL] [Abstract][Full Text] [Related]
39. Synthetic triglyceride containing an arachidonic acid branch (8A8) prevents lipopolysaccharide-induced liver injury.
Piao N; Ikejima K; Kon K; Aoyama T; Osada T; Takei Y; Sato N; Watanabe S
Life Sci; 2009 Oct; 85(17-18):617-24. PubMed ID: 19647752
[TBL] [Abstract][Full Text] [Related]
40. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN
J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
